Nonsurgical management of ankylosing spondylitis

Neurosurgical Focus

Volumn 24, Issue 1, 2008, Pages

  Sangala, Jaypal Reddy ^a   Dakwar, Elias ^a   Uribe, Juan S ^a   Vale, Fernando ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Ankylosing spondylitis; Nonsurgical management; Pharmacological therapy; Tumor necrosis factor

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; IMMUNOLOGIC FACTOR;

ANKYLOSING SPONDYLITIS; HUMAN; PATHOLOGY; PATIENT EDUCATION; PHYSIOTHERAPY; REVIEW;

ANALGESICS; ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; HUMANS; IMMUNOLOGIC FACTORS; PATIENT EDUCATION AS TOPIC; PHYSICAL THERAPY MODALITIES; SPONDYLITIS, ANKYLOSING;

EID: 41949107680     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/FOC/2008/24/1/E5     Document Type: Review

References (27)

1. Altan L, Bingöl U, Aslan M, Yurtkuran M: The effect of balneotherapy on patients with ankylosing spondylitis. Scand J Rheumatol 35:283-289, 2006
2. Basler HD, Rehfisch HP: Cognitive-behavioral therapy in patients with ankylosing spondylitis in a German self-help organization. J Psychosom Res 35:345-354, 1991
3. Braun J, Baraliakos X, Brandt J, Listing J, Zink A, Alten R, et al: Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years. Rheumatology (Oxford) 44:1670-676, 2005
4. Braun J, Pham, T, Sieper J, Davis J, van der Linden S, Dougados; M, et al: International ASAS consensus statement for the use of anti-tumor necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 62:817-824, 2003
5. Braun J, Sieper J: Ankylosing spondylitis. Lancet 369: 1379-1390, 2007
6. Calin A, Dijkmans BA, Emery P, Hakala M, Kalden J, Leirisalo-Repo M, et al: Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis 63: 1594-1600, 2004
7. Chen J, Liu C: Is sulfasalazine effective in ankylosing spondylitis? A systematic review of randomized controlled trials. J Rheumatol 33:722-731, 2006
8. Chen J, Liu C: Methotiexate for ankylosing spondylitis. Cochrane Database Syst Rev 4: CDO04524, 2004
9. Claudepierre P: Spa therapy for ankylosing spondylitis: still useful? Joint Bone Spine 72:283-285, 2005
10. Dagfinrud H, Kvien TK, Hagen KB: Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 4: CDO02822, 2004
11. Davis JC Jr, Van Der Heijde D, Braun J, Dougados; M, Cush J, Clegg DO, et al: Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 48:3230-3236, 2003
12. Dougados M, Dijkmans B, Khan M, Maksymowych W, van der Linden S, Brandt J: Conventional treatments for ankylosing spondylitis. Ann Rheum Dis 61 (3 Suppl):40-50, 2002
13. Haibel H, Rudwaleit M, Brandt HC, Grozdanovic Z, Listing J, Kupper H, et al: Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial. Arthritis Rheum 54: 678-681, 2006
14. Haibel H, Rudwaleit M, Listing J, Sieper J: Open label trial of anakinra in active ankylosing spondylitis over 24 weeks. Ann Rheum Dis 64:296-298, 2005
15. Maugars Y, Mathis C, Berthelot JM, Charlier C, Prost A: Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a double-blind study. Br J Rheumatol 35: 767-770, 1996
16. McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, et al: Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Health Technol Assess 11:1-158, 2007
17. Pal B: Use of simple analgesics in the treatment of ankylosing spondylitis. Br J Rheumatol 26:207-209, 1987.
18. Pham T, van der Heijde D, Caliit A, Khan MA, van der Linden S, Bellamy N, et al: Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group. Ann Rheum Dis 62:812-816, 2003
19. Radi ZA, Khan NK: Effects of cyclooxygenase inhibition on bone, tendon, and ligament healing. Inflamm Res 54:358-366, 2005
20. Rehart S, Kerschbaumer F, Braun J, Sieper J: [Modern treatment of ankylosing spondylitis.] Orthopade 36:963-974, 2007 (Ger)
21. Tan AL, Marzo-Ortega H, O'Connor P, Fraser A, Emery P, Mc-Gonagle D: Efficacy of anakinra in active ankylosing spondylitis. a clinical and magnetic resonance imaging study. Ann Rheum Dis 63:1041-1045, 2004
22. van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, et al: Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 52:582-591, 2005
23. Visvanathan S, Wagner CL, Marini JC, van der Heijde D, Baker D, Gathany T; et al: Inflammmry biomarkers, disease activity, and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Ann Rheum Dis [epub ahead of print], 2007
24. Wandeirs A, Heijde D, Landewé R, Béhier JM, Calin A, Olivieri I, et al: Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 52:1756-1765, 2005
25. Zochling J, Braun J: Management and treatment of ankylosing spondylitis. Curr Opin Rheumatol 17:418-425, 2005
26. Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B, et al: ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65:442-452, 2006
27. Zochling J, van der Heijde D, Dougados M, Biraw J: Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Ann Rheum Dis 65:423-432, 2006